Cancer-related fatigue in Chinese patients with cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study collects patient questionnaires alongside medical records and follow-up information to measure cancer-related fatigue and its severity using standardized tools. It analyzes variables such as tumor type, treatment regimen, disease stage, treatment effectiveness, side effects, and concomitant medications to identify factors associated with fatigue. It also explores how fatigue may affect anti-tumor treatment decisions and prognosis. Data from imaging, lab results, and follow-up visits help assess the relationship between fatigue levels and patient outcomes. No interventions are performed; this study observes real-world experiences.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male or female, aged 18 years or older.
2. Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
3. Malignant tumor confirmed histologically or cytologically.

Exclusion Criteria:

1. Pregnant or breastfeeding women.
2. Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
3. Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
4. Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
5. Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
6. Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.

Where it's running

• Fudan University Shanghai Cancer Center
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Hongxia Wang, PhD
• Email: whx365@126.com
• Phone: 021-33988888

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease in Real World Practice

  This study will look at real-world safety and effectiveness of disease-modifying therapy (DMT) in adults with MCI or Alzheimer's dementia by comparing those who receive DMT in routine care to those who do not.

  Recruiting Fudan University · Shanghai, Jingan · NCT07923812

• ctDNA methylation-guided adjuvant therapy after removing colorectal liver metastases

  This trial tests whether using a blood test that detects ctDNA methylation after surgery can guide adjuvant therapy for patients who had colorectal cancer spread to the liver and were operated on with no remaining disease.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT07917104

• China HEAD: a large community study on healthy aging and dementia

  This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.

  Recruiting at 30 sites Fudan University · Beijing and 29 other locations · NCT07912710

• Becotatug Vedotin plus Pucotenlimab for EGFR-positive metastatic colorectal cancer

  This study tests whether combining becotatug vedotin with pucotenlimab can shrink tumors in adults with colorectal cancer that has returned or spread after at least two prior treatments and whose tumors express EGFR.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT07884188

• ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer

  This study tests whether tracking ctDNA can guide neoadjuvant immunotherapy and surgical decisions for people with dMMR/MSI-H colon cancer, using PD-1 inhibitors first and adding CTLA-4 inhibitors if ctDNA remains detectable.

  Recruiting Phase 2 Fudan University · Shanghai · NCT07841236

• Hypofractionated vs. standard radiotherapy after mastectomy with implant reconstruction

  This trial tests whether shorter, higher-dose radiotherapy schedules after implant-based mastectomy reconstruction work as well as the traditional longer schedules for preventing unplanned reoperations.

  Recruiting Fudan University · Shanghai · NCT07835139

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.